Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo

Pegylated liposomal doxorubicin (PLD, Doxil, Caelyx) is widely used for the treatment of ovarian cancer. It is a stable formulation encapsulating doxorubicin in a ‘Stealth’ (i.e., pegylated) liposome with a half-life of about 72 hours. This drastically altered pharmacology confers on it a considerab...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yuan, Y, Orlow, SJ, Curtin, J, Downey, A, Muggia, F
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cancer Intelligence 2008
Konular:
Case Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3234058/
https://ncbi.nlm.nih.gov/pubmed/22275986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2008.111
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller